CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
3.750
-0.180 (-4.58%)
At close: Aug 29, 2025, 4:00 PM
3.850
+0.100 (2.67%)
After-hours: Aug 29, 2025, 7:20 PM EDT

CapsoVision Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for CapsoVision stock has a target of 5.00, which predicts a 33.33% increase from the current stock price of 3.75.

Price Target: $5.00 (+33.33%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$5.00$5.00$5.00$5.00
Change+33.33%+33.33%+33.33%+33.33%
* Price targets were last updated on Jul 28, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for CapsoVision is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingAug '25
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
Total1

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Benchmark
Benchmark
Buy
Initiates
$5
BuyInitiates$5+33.33%Jul 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
14.51M
from 11.76M
Increased by 23.40%
Revenue Next Year
27.58M
from 14.51M
Increased by 90.10%
EPS This Year
-0.68
from -9.76
EPS Next Year
-0.33
from -0.68
Fiscal YearFY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
9.75M11.76M14.51M27.58M54.49M
Revenue Growth
-20.54%23.40%90.10%97.57%
EPS
-6.36-9.76-0.68-0.33-0.01
EPS Growth
-----
Forward PE
-----
No. Analysts
--554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High14.9M35.5M
Avg14.5M27.6M
Low13.7M19.4M

Revenue Growth

Revenue Growth202520262027
High
26.5%
144.6%
Avg
23.4%
90.1%
Low
16.7%
33.4%

EPS Forecast

EPS202520262027
High-0.55-0.23
Avg-0.68-0.33
Low-0.79-0.42

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.